Medgold Resources Corp

Medgold taps Crozier as acting president and grants stock options

Jeremy Crozier replaces Dan James who is stepping down as president after six years in the post

gold bars and cash
Crozier boasts experience in the management of complex mineral projects in remote environments

Medgold Resources Corp (CVE:MED) announced Wednesday that Jeremy Crozier has been tapped as its acting president.

Crozier, who boasts years of technical and commercial experience in the resource industry, replaces Dan James who is stepping down as president and a director of the gold exploration company after six years in the post.

READ: Medgold Resources completes 2018 gold drilling in southern Serbia

In a statement, Simon Ridgway, chairman and CEO of Medgold, said he was bullish on Crozier's appointment.

“On behalf of the Board, I would like to welcome Jeremy to the team. Jeremy holds BSc and MSc degrees in geology and has over 20 years of exploration and commercial experience gained across a variety of project operations in Europe, North America and Africa,” Ridgway said.

“I would like to take this opportunity to thank Dan James for his services over the past six years as Medgold’s President,” he added.

READ: Medgold gearing up for second phase of drilling at Tlamino after recent potential "significant discovery"

Crozier boasts experience in the management of complex mineral projects in remote environments as well as in the identification and appraisal of merger and acquisition opportunities. He also worked on capital raising and negotiating transactions with property vendors and joint venture partners in the past.

In separate news, Medgold has cancelled 300,000 outstanding incentive stock options and granted new stock options to staff who will be able to purchase up to an aggregate of 2 million common shares which are exercisable for up to 10 years at a price of C$0.15 per share.

Vancouver-based Medgold is an exploration company targeting early-stage gold properties in the Oligo-Miocene Belt of Serbia.

Medgold shares finished 4% higher to hit C$0.13 on Tuesday.

Contact Ellen Kelleher at [email protected]

Quick facts: Medgold Resources Corp

Price: $0.12

Market: TSX-V
Market Cap: $11.37 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Arcadia Biosciences makes major progress on its hemp venture...

Arcadia Biosciences Inc (NASDAQ:RKDA) CEO Raj Ketkar tells Proactive the California-based company expects to “significantly scale revenues in 2020” as it reported financial and business results for the second quarter and first half of 2019. Ketkar says the agricultural innovation company made...

2 days, 4 hours ago

2 min read